TerminatedPhase 1NCT00800150
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- City of Hope Medical Center
- Principal Investigator
- Joseph Rosenthal, MDCity of Hope Comprehensive Cancer Center
- Intervention
- fludarabine phosphate(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00800150 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.